Journal of Commercial Biotechnology (2009) 15, 73–85. doi:10.1057/jcb.2008.50
Legal and Regulatory Update
ReedSmith
Content is compiled and written by Reed Smith
Reed Smith is one of the leading life sciences law firms and one of the 25 largest firms worldwide with over 1000 lawyers across 15 US, four European cities and four cities in the Middle East and Asia. A strong presence on both coasts of the United States and offices in the UK, France and Germany makes us ideally positioned to offer clients a full-service, transatlantic capability as well as emerging markets in the Middle and Far East.
We represent clients, large and small, across a great number of legal disciplines and many industry sectors. In Europe, our key industries are financial services and life sciences. Our firmwide clients include financial institutions, biotechnology and pharmaceutical companies, manufacturers, health care providers and insurers, communications companies, universities and real estate developers and government bodies on both sides of the Atlantic.
This section is intended to be a synopsis of recent legal developments and is not intended to be exhaustive. If any issue referred to in this section to be relied upon, specific advice should be sought.
Please contact:
John Wilkinson
Reed Smith
Minerva House
5 Montague Place
London SE1 9BB
Tel: +44 (0)20 7403 2900
Fax: +44 (0)20 7403 4221
Email: jwilkinson@reedsmith.com
